Clinical significance of reduced GPRC5A expression in surgically resected non‑small cell lung cancer
Er Jin(Hangzhou First People's Hospital), Shenglin Ma(North University of China)
Cited by 12
Related Papers
Final Overall Survival Results from a Phase III, Randomized, Placebo-Controlled, Parallel-Group Study of Gefitinib Versus Placebo as Maintenance Therapy in Patients with Locally Advanced or Metastatic Non–Small-Cell Lung Cancer (INFORM; C-TONG 0804)
|Journal of Thoracic Oncology|2015|44
Effect of Paris saponin I on radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line
|Oncology Letters|2014|39
Chalcomoracin inhibits cell proliferation and increases sensitivity to radiotherapy in human non-small cell lung cancer cells via inducing endoplasmic reticulum stress-mediated paraptosis
|Acta Pharmacologica Sinica|2020|36
Role of transcription factor FOXA1 in non‑small cell lung cancer
|Molecular Medicine Reports|2017|28
Genome-wide profiling reveals alternative polyadenylation of mRNA in human non-small cell lung cancer
|Journal of Translational Medicine|2019|26